Covalent oligonucleotide-horseradish peroxidase conjugate
    1.
    发明授权
    Covalent oligonucleotide-horseradish peroxidase conjugate 失效
    共价寡核苷酸 - 辣根过氧化物酶缀合物

    公开(公告)号:US4962029A

    公开(公告)日:1990-10-09

    申请号:US437311

    申请日:1989-11-16

    CPC classification number: C07H21/00 Y10S435/964

    Abstract: Oligonucleotides derivatized to incorporate horseradish peroxidase (HRP) are useful in diagnostic methods and provide significant advantage over radioactively labeled oligonucleotide probes. The HRP-derivatized oligonucleotides can be easily and efficiently prepared by reacting a sulfhydryl containing oligonucleotide with a conjugate of a mal-sac-HNSA ester and HRP under mild and easily controlled reaction conditions.

    Abstract translation: 衍生成掺入辣根过氧化物酶(HRP)的寡核苷酸可用于诊断方法,并且比放射性标记的寡核苷酸探针提供显着的优点。 通过在温和且容易控制的反应条件下使含巯基的寡核苷酸与mal-sac-HNSA酯和HRP的缀合物反应,可以容易且有效地制备HRP衍生的寡核苷酸。

    D-enantiomer of DFMO and methods of use therefor

    公开(公告)号:US06602910B2

    公开(公告)日:2003-08-05

    申请号:US09801197

    申请日:2001-03-06

    Abstract: The present invention concerns a method for preventing and/or treating cancer in a patient comprising administering an effective amount of substantially purified D enantiomer of difluoromethylornithine (D-DFMO) or an analog of D-DFMO to the patient. D-DFMO or an analog thereof is administered at a dose of about 0.05 to about 20.0 gm/M2/day. D-DFMO or an analog thereof may be administered more than once for the treatment and/or prevention of cancer. Methods of administration as well as compositions and formulations of substantially purified D-DFMO and analogs of D-DFMO are described.

Patent Agency Ranking